Biocause Pharmaceutical's Insurance Arm Accumulates 35 Billion Yuan in 2024 Insurance Premium Income

MT NewswiresJan 13 00:09 ET

It's Down 27% But Hubei Biocause Pharmaceutical Co., Ltd. (SZSE:000627) Could Be Riskier Than It Looks

Simply Wall StJan 6 18:30 ET

Strong Week for Hubei Biocause Pharmaceutical (SZSE:000627) Shareholders Doesn't Alleviate Pain of Five-year Loss

Simply Wall StNov 29, 2024 21:14 ET

Biocause Pharma's Insurance Unit Logs 31 Billion Yuan Insurance Premium Income in January-October Period

MT NewswiresNov 11, 2024 22:59 ET

Hubei Biocause Pharmaceutical Co., Ltd.'s (SZSE:000627) Shares Leap 43% Yet They're Still Not Telling The Full Story

Simply Wall StOct 23, 2024 18:02 ET

Private Companies Invested in Hubei Biocause Pharmaceutical Co., Ltd. (SZSE:000627) Copped the Brunt of Last Week's CN¥2.0b Market Cap Decline

Simply Wall StOct 10, 2024 18:19 ET